Country: Malaysia
Bahasa: Inggeris
Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
KETOROLAC TROMETHAMINE
Allergan Malaysia Sdn Bhd
KETOROLAC TROMETHAMINE
3ml mL; 5ml mL; 10ml mL
ALLERGAN PHARMACEUTICALS IRELAND
ACULAR ® OPHTHALMIC SOLUTION Ketorolac tromethamine (0.5% w/v) _CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_ WHAT IS IN THIS LEAFLET 1. What ACULAR ® is used for 2. How ACULAR ® works 3. Before you use ACULAR ® 4. How to use ACULAR ® 5. While you are using it 6. Side effects 7. Storage and Disposal of ACULAR ® 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of revision WHAT ACULAR ® IS USED FOR ACULAR ® ophthalmic solution is indicated for the short-term relief of itchy eyes due to seasonal eye allergy and for the prevention and relief of eye inflammation following eye surgery. HOW ACULAR ® WORKS ACULAR ® belongs to a group of medicines known as non-steroidal anti- inflammatory drugs (NSAIDs). The active ingredient in ACULAR ® is ketorolac tromethamine. The eye solution of Ketorolac tromethamine works by decreasing prostaglandin E2 levels in the eye. Prostaglandins are normally produced by the body, but in the eye they are thought to be associated with pain, itching and inflammation. BEFORE YOU USE ACULAR ® - _ When you must not use it_ swelling of the face, lips, tongue, throat or other parts of the body; rash, itching or hives on the skin; fainting; or hay fever-like symptoms. - _ Pregnancy and lactation_ Ask your doctor or pharmacist for advice before using any medicine. ACULAR ® should not be used if you are pregnant or might become pregnant or are breast feeding, unless your doctor recommends it. - _ Children_ The use of ACULAR ® in children has not been studied. - _ Before you start use it_ Take special care with ACULAR ® . If any of the following apply, talk to your doctor before using ACULAR ® . If you suffer from, or have in the past suffered from: - Viral or bacterial infections of the eye - Bleeding tendencies (for example, anaemia) or stomach ulcers - or if you have had recent eye surgery - you have had an allergy to any medicines or any other substances, such as foods, preservatives or dyes. - you have defects of the cornea, diseases of the eye , or Baca dokumen lengkap
ACULAR ® ketorolac tromethamine 0.5% Sterile Ophthalmic Solution DESCRIPTION Each mL contains: ketorolac tromethamine 5 mg with: benzalkonium chloride 0.1 mg, edetate disodium 1 mg, octoxynol 40, sodium chloride, and purified water. ANIMAL PHARMACOLOGY Ketorolac tromethamine prevented the development of increased intraocular pressure induced in rabbits with topically applied arachidonic acid. Ketorolac did not inhibit rabbit lens aldose reductase in vitro . Ketorolac tromethamine ophthalmic s olution did not enhance the spread of ocular infections induced in rabbits with Candida albicans, Herpes simplex virus type one, or Pseudomonas aeruginosa . CLINICAL PHARMACOLOGY Ketorolac tromethamine is a nonsteroidal anti -inflammatory drug which, when ad ministered systemically, has demonstrated analgesic, anti -inflammatory and anti - pyretic activity. The mechanism of its action is thought to be due, in part, to its ability to inhibit prostaglandin biosynthesis. Ocular administration of ketorolac tromethami ne reduces prostaglandin E 2 levels in aqueous humor. The mean concentration of PGE 2 was 80 pg/mL in the aqueous humor of eyes receiving vehicle and 28 pg/mL in the eyes receiving 0.5% ACULAR ® ophthalmic solution . Ketorolac tromethamine given systemically d oes not cause pupil constriction. Results from clinical studies indicate that ACULAR ® ophthalmic solution has no significant effect upon intraocular pressure. Two controlled clinical studies showed that ACULAR ® ophthalmic solution was significantly more ef fective than its vehicle in relieving ocular itching caused by seasonal allergic conjunctivitis. Two controlled clinical studies showed that patients treated for two weeks with ACULAR ® ophthalmic solution were less likely to have measurable signs of inflam mation (cell and flare) than patients treated with its vehicle. Two drops (0.1 mL) of 0.5% ACULAR ® ophthalmic solution instilled into the eyes of patients 12 hours and 1 hour prior to cataract extraction achieved measurable levels in 8 of 9 patie Baca dokumen lengkap